Insider Shareholders with Direct Ownership of Kala Pharmaceuticals, Inc. (KALA)
This section provides a comprehensive overview of the insiders with direct ownership of Kala Pharmaceuticals, Inc. (KALA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Kala Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Hongming Chen
CHIEF SCIENTIFIC OFFICER |
140,166 | 38,500 | 204,515 $153,386 | 8 |
Oct 27, 2021
Reduced 9.33%
|
| 576,304 | 254,435 | 103,540 $77,655 | 21 |
Oct 23, 2025
Reduced 59.94%
|
|
| 150,989 | 18,845 | 68,066 $51,049 | 13 |
Jan 04, 2024
Reduced 1.77%
|
|
|
Darius Kharabi
CHIEF BUSINESS OFFICER |
366,354 | 34,851 | 41,760 $31,320 | 15 |
Oct 22, 2025
Reduced 33.25%
|
| 20,000 | 0 | 40,000 $30,000 | 1 |
Jun 17, 2021
Added 33.33%
|
|
| 20,000 | 0 | 40,000 $30,000 | 1 |
Jun 17, 2021
Added 33.33%
|
|
| 205,172 | 90,013 | 35,952 $26,964 | 20 |
Oct 22, 2025
Reduced 56.53%
|
|
| 207,756 | 87,637 | 35,932 $26,949 | 20 |
Oct 22, 2025
Reduced 57.07%
|
|
|
Mary Reumuth
CHIEF FINANCIAL OFFICER |
158,771 | 66,178 | 28,906 $21,679 | 21 |
Oct 23, 2025
Reduced 3.24%
|
| 20,000 | 0 | 20,000 $15,000 | 1 |
Jun 17, 2021
Added 50.0%
|
|
| 40,912 | 0 | 16,972 $12,729 | 5 |
Jun 15, 2025
Added 15.23%
|
|
| 35,440 | 0 | 16,240 $12,180 | 5 |
Jun 15, 2025
Added 13.11%
|
|
| 32,544 | 0 | 13,344 $10,008 | 5 |
Jun 15, 2025
Added 15.51%
|
|
| 167,702 | 3 | 13,091 $9,818 | 6 |
Jun 11, 2024
Added 9.66%
|
|
| 10,374 | 0 | 10,374 $7,780 | 4 |
Jun 15, 2025
Added 19.1%
|
|
| 10,242 | 0 | 10,242 $7,681 | 4 |
Jun 15, 2025
Added 19.3%
|